FrancophonIA/ELRC3.0 huggingface dataset:
English: Remsima is indicated for treatment of severe, active Crohn's disease in children and adolescents aged 6 to 17 years, who have not responded to conventional therapy including a corticosteroid, an immunomodulator and primary nutrition therapy; or who are intolerant to or have contraindications for such therapies.
Maltese: 17-il sena, li ma kellhomx rispons għat-terapija konvenzjonali inklużi kortikosterojd, immunomodulatur u terapija ta' nutrizzjoni primarja, jew li huma intolleranti jew għandhom kontraindikazzjonijiet għal dawn it-tipi ta' terapiji.
English: Infliximab treatment reduced the rate of progression of peripheral joint damage compared with placebo treatment at the week 24 primary endpoint as measured by change from baseline in total modified vdH-S score (mean ± SD score was 0.82 ± 2.62 in the placebo group compared with -0.70 ± 2.53 in the infliximab group; p<0.001).
Maltese: Il-kura b'infliximab naqqset r-rata tal-avvanz tal-ħsara periferali fil-ġogi meta mqabbla mal-kura bi plaċebo fil-punt aħħari primarju ta' ġimgħa 24 hekk kif imkejla mill-bidla mil linja bażi fil-punteġġ totali modifikat ta' vdH-S (medja ± punteġġ SD kien 0.
English: In post-marketing experience, cases of anaphylactic-like reactions, including laryngeal/pharyngeal oedema and severe bronchospasm, and seizure have been associated with infliximab intravenous administration (see section 4.4).
Maltese: karċinoma taċ-ċellula ta' Merkel, melanoma, sarkojdosi/ reazzjoni li tixbah lil sarkojdosi, u reazzjonijiet serji għall-infużjoni (ara sezzjoni 4.4).
English: In a 6-month repeated dose toxicity study in mice, using the same analogous antibody against mouse TNFα, crystalline deposits were observed on the lens capsule of some of the treated male mice.
Maltese: Fi studju li dam 6 xhur dwar tossiċità b'dożi ripetuti li sar filġrieden, fejn intuża l-istess antikorp analogu kontra TNFα tal-ġrieden, depożiti kristallini kienu osservati fuq il-kapsula tal-lenti ta' wħud mill-ġrieden irġiel ikkurati.
English: Infliximab + MTX
Maltese: Infliximab + MTX Plaċebo + MTX 3 mg/kg 6 mg/kg Flimkien
English: b. Gently press a cotton ball or gauze over the injection site and hold for 10 seconds.
Maltese: b. Agħfas ġentilment tajjara jew garża fuq is-sit talinjezzjoni u żommha għal 10 sekondi.
English: PASI 75 response** * ITT-analysis where subjects with missing data were included as non-responders.
Maltese: PASI 75** * Analiżi-ITT fejn l-individwi b'dejta nieqsa kienu kkunsidrati ma' dawk li ma kellhomx rispons.
English: Neoplasms benign, malignant and unspecified (including cysts and polyps) Rare:
Maltese: Neoplażmi beninni, malinni u dawk mhux speċifikati (inklużi ċesti u polipi)
English: In clinical studies with intravenous infliximab, delayed hypersensitivity reactions have been uncommon and have occurred after infliximab-free intervals of less than 1 year (see sections 4.4 and 4.8).
Maltese: Fi studji kliniċi, reazzjonijiet ta' sensittività eċċessiva li damu ma seħħew ma kinux komuni u seħħew wara intervalli mingħajr l-użu ta' infliximab ta' anqas minn sena (ara sezzjoni 4.4 u 4.8).
English: Adequate data of treating patients who are carriers of HBV with antiviral therapy in conjunction with TNF-antagonist therapy to prevent HBV reactivation are not available.
Maltese: M'hemmx dejta adegwata dwar il-kura ta' pazjenti li jġorru HBV b'terapija antivirali flimkien ma' antagonist-TNF sabiex tiġi evitata l attivazzjoni mill-ġdid tal-HBV.
English: Each 1 ml single dose pre-filled syringe contains 120 mg of infliximab.
Maltese: Kull 1 mg siringa mimlija għal-lest ta' doża waħda fiha 120 mg ta' infliximab.
English: The primary endpoint of the study was corticosteroid-free clinical remission at week 26, defined as patients in clinical remission (CDAI of <150) who, for at least 3 weeks, had not taken oral systemic corticosteroids (prednisone or equivalent) or budesonide at a dose >6 mg/day.
Maltese: Il-punt aħħari primarju tal-istudju kien in-nuqqas totali ta' sinjali u sintomi kliniċi mingħajr kortikosterojdi f'ġimgħa 26, definit bħala dawk il-pazjenti b'nuqqas totali ta' sinjali u sintomi kliniċi (CDAI ta' < 150) li, għal mill-anqas 3 ġimgħat, ma kinux ħadu kortikosterojdi sistemiċi mill-ħalq (prednisone jew ekwivalenti) jew budesonide f'doża ta' > 6 mg/kuljum.
English: * p-values represent each infliximab treatment group vs. AZA monotherapy.
Maltese: * Il-valuri P jirrappreżentaw kull grupp ta' kura b'infliximab vs. terapija b'AZA waħdu.
English: The most common adverse event was worsening of ulcerative colitis, the incidence of which was higher in patients on the q12 week vs. the q8 week dosing regimen.
Maltese: rispettivament, fil-gruppi ta' manteniment kombinati tal-ġimgħat q8 u ġimgħat q12.
English: It is important to check the product labels to ensure that the correct formulation is being given as prescribed.
Maltese: Huwa importanti li tiċċekkja t-tikketti tal-prodott biex tiżgura li tkun qed tingħata l formulazzjoni korretta skont ir-riċetta tat-tabib.
English: Remsima 120 mg solution for injection in pre-filled syringe with automatic needle guard Remsima 120 mg solution for injection in single-use pre-filled syringe with automatic needle guard.
Maltese: Remsima 120 mg soluzzjoni għal injezzjoni ġo siringa mimlija għal-lest Remsima 120 mg soluzzjoni għal injezzjoni f'pinna mimlija għal-lest
English: Cyanosis, pericardial effusion
Maltese: Fetħiet anormali fil-ġilda
English: • you are allergic to infliximab or any of the other ingredients of this medicine (listed in section 6),
Maltese: • inti allerġiku għal infliximab jew għal xi sustanza oħra ta' din il-mediċina (elenkati fis sezzjoni 6),
English: In an exploratory clinical study evaluating the use of infliximab in patients with moderate to severe chronic obstructive pulmonary disease (COPD), more malignancies were reported in infliximabtreated patients compared with control patients.
Maltese: Fi studju kliniku ta' stħarriġ li evalwa l-użu ta' infliximab f'pazjenti b'mard ostruttiv kroniku talpulmun (COPD) minn moderat sa sever, kien hemm aktar tumuri rrappurtati fil-pazjenti kkurati b'infliximab meta mqabbla ma' pazjenti tal-kontroll.
English: Data about fistulas were derived from PCDAI scores.
Maltese: • Id-data ta' skadenza għaddiet.
English: For volumes greater than 250 ml, either use a larger infusion bag (e.g. 500 ml, 1000 ml) or use multiple 250 ml infusion bags to ensure that the concentration of the infusion solution does not exceed 4 mg/ml.
Maltese: Il-volum meħtieġ tas-soluzzjoni ta' Remsima rikostitwita għandu jiżdied bil-mod mal-flixkun jew borża tal-infużjoni ta' 250 mL u jitħallat bil-mod. Għal volumi akbar minn 250 ml, uża borża talinfużjoni akbar (eż. 500 ml, 1000 ml) jew uża boroż tal-infużjoni ta' 250 ml multipli biex tkun ċert li l-konċentrazzjoni tas-soluzzjoni għall-infużjoni ma tkunx aktar minn 4 mg/ml.
English: Remsima 120 mg solution for injection in pre-filled syringe infliximab
Maltese: Remsima 120 mg soluzzjoni għal injezzjoni ġo siringa mimlija għal-lest infliximab
English: c. With a quick and “dart-like” motion, insert the needle completely into the fold of the skin at a 45-degree angle.
Maltese: B'moviment veloċi u qisek qed twaddab dart, daħħal il-labra għal kollox fil-qarsa tal-ġilda f'angolu ta' 45 grad.
English: Median
Maltese: Tieqa
English: The primary endpoint was the proportion of patients who experienced a clinical response, defined as ≥50% reduction from baseline in the number of fistulae draining upon gentle compression on at least two consecutive visits (4 weeks apart), without an increase in the use of medicinal products or surgery for Crohn's disease.
Maltese: Il-punt aħħari primarju kien ilproporzjon ta' pazjenti li kellhom rispons kliniku, definit bħala tnaqqis ta' ≥ 50% mil-linja bażi finnumru ta' fistuli li jnixxu meta jkunu magħfusa bil-mod mill-inqas f'żewġ eżamijiet konsekuttivi (b'4 ġimgħat bejniethom), mingħajr żieda fl-użu tal-prodotti mediċinali jew kirurġija għal marda ta'
English: • 1 prefilled pen (1 mL sterile solution) with 2 alcohol pads.
Maltese: • 1 pinna mimlija għal-lest (1 mL soluzzjoni sterili) b'2 pads tal-alkoħol.
English: Note: You may see air bubbles in the liquid.
Maltese: Nota: Tista' tara bżieżaq tal-arja fil-likwidu.
English: Patients should seek immediate medical attention if developing symptoms of serious allergic reactions (see section 4.4).
Maltese: Il pazjenti għandhom ifittxu attenzjoni medika immedjata jekk jiżviluppaw sintomi ta' reazzjonijietallerġiċi serji (ara sezzjoni 4.4).
English: Infliximab has been associated with systemic injection reactions, anaphylactic shock and delayed hypersensitivity reactions (see section 4.8).
Maltese: Infliximab kien assoċjat ma' reazzjonijiet ta' injezzjoni sistemika, xokk anafilattiku u reazzjonijiet ta' sensittività eċċessiva li jdumu ma jseħħu (ara sezzjoni 4.8).
English: Controla
Maltese: Rispons
English: • Inflamed liver caused by a problem with the immune system (autoimmune hepatitis)
Maltese: • Infezzjoni tal-epatite B jekk kellek epatite B fil-passat • Fwied infjammat ikkawżat minn problema bis-sistema immuni tiegħek (epatite awtoimmuni)
English: In Crohn's disease patients who received maintenance treatment, antibodies to infliximab occurred overall in 3.3% of patients receiving immunosuppressants and in 13.3% of patients not receiving immunosuppressants.
Maltese: Fil-pazjenti bil-marda ta' Crohn li rċevew kura ta' manteniment, antikorpi għal infliximab seħħew f'total ta' 3.3% tal-pazjenti li kienu qed jirċievu immunosoppressanti u fi 13.3% tal-pazjenti li ma kinux qed jirċievu immunosoppressanti. Linċidenza ta' antikorpi kienet xi 2-3 darbiet ogħla f'pazjenti li kienu kkurati b'mod episodiku.
English: The analysis of other efficacy endpoints showed that efficacy profile of Remsima subcutaneous formulation compared to Remsima intravenous formulation in RA patients was generally comparable in terms of disease activity measured by DAS28 (CRP and ESR) and ACR response up to Week 54.
Maltese: L-analiżi ta' punti ta' tmiem tal-effikaċja oħrajn uriet li l-profil tal-effikaċja ta' Remsima formulazzjoni taħt il-ġilda meta mqabbel ma' Remsima formulazzjoni ġol-vina f'pazjenti RA kien ġeneralment komparabbli f'termini tal-attività tal-marda mkejla b'rispons ta' DAS28 (CRP u ESR) u
English: Place the pen on the injection site (see Figure E).
Maltese: Poġġi l-pinna fis-sit tal-injezzjoni (ara l-Figura E).
English: b CDAI <150 at both Week 30 and 54 and not receiving corticosteroids in the 3 months prior to
Maltese: L-istudju ATTRACT evalwa r-risponsi f'ġimgħa 30, 54 u 102 fl-istudju kkontrollat bi plaċebo fuq
English: Table 1 lists the ADRs based on experience from clinical studies as well as adverse reactions, some with fatal outcome, reported from post-marketing experience.
Maltese: Tabella 1 Reazzjonijiet avversi fi studji kliniċi u mill-esperjenza ta' wara t-tqegħid fis-suq ta' infliximab ġol-vini
English: Currently available pharmacokinetic data are described in section 5.2 but no recommendation on a posology can be made in children younger than 6 years.
Maltese: Dejta farmakokinetika disponibbli hi deskritta fis-sezzjoni 5.2 imma l-ebda rakkomandazzjoni dwar il pożoloġija ma tista' tingħata fi tfal li għandhom inqas minn 6 snin.
English: Keratitis, periorbital oedema, hordeolum
Maltese: • Uġigħ fl-istonku, dardir
English: When switching from the maintenance therapy of infliximab intravenous formulation to the subcutaneous formulation of Remsima, the subcutaneous formulation may be administered 8 weeks after the last administration of the intravenous infusions of infliximab 3 mg/kg given every 8 weeks.
Maltese: Meta jsir qlib mit-terapija ta' manteniment ta' formulazzjoni ġol-vina ta' infliximab għallformulazzjoni taħt il-ġilda ta' Remsima, il-formulazzjoni taħt il-ġilda tista' tiġi amministrata 8 ġimgħat wara l-aħħar għoti tal-infużjonijiet ġol-vini ta' infliximab 3 mg/kg mogħtija kull 8 ġimgħat.
English: Remsima treatment is to be initiated and supervised by qualified physicians experienced in the diagnosis and treatment of rheumatoid arthritis, inflammatory bowel diseases, ankylosing spondylitis, psoriatic arthritis or psoriasis.
Maltese: Artrite idjopatika ġuvenili, artrite psorijatika u ankylosing spondylitis
English: Discontinuation of infliximab should be considered if these disorders develop.
Maltese: infliximab + methotrexate meta mqabbla ma' methotrexate waħdu.
English: Infusion-related reaction, pain.
Maltese: injezzjoni subkutaneja biss.
English: In clinical studies with infliximab in which 5,780 patients were treated, representing 5,494 patient years, 5 cases of lymphomas and 26 non-lymphoma malignancies were detected as compared with no lymphomas and 1 non-lymphoma malignancy in 1,600 placebo-treated patients representing 941 patient years.
Maltese: pazjenti, 5 każijiet ta' limfomi u 26 tumur malinni mhux limfomi nstabu meta mqabbla mal-ebda każ ta' limfoma u każ wieħed ta' tumur malinn mhux limfoma f'1,600 pazjent ikkurati bi plaċebo li jirrapreżentaw 941 sena ta' pazjenti.
English: • 2 prefilled pens (1 mL sterile solution) with 2 alcohol pads.
Maltese: • 2 pinen mimlijin għal-lest (1 mL soluzzjoni sterili) b'2 pads tal-alkoħol.
English: The number of ulcerative colitis-related surgical procedures was also lower in the 5 and 10 mg/kg infliximab treatment groups than in the placebo group (mean number of surgical procedures per 100 subject-years: 22 and 19 vs. 34; p=0.145 and p=0.022, respectively).
Maltese: In-numru ta' operazzjonijiet kiruġiċi relatati mal-kolite ulċerattiva kien ukoll aktar baxx fil-gruppi ikkurati b'5 u 10 mg/kg infliximab milli fil-grupp tal-plaċebo (il-medja tan numru ta' dawk li kellhom operazzjonijiet kirurġiċi għal kull 100 sena ta' individwu: 22 u 19 kontra
English: For subsequent injections and after proper training in subcutaneous injection technique, patients may self-inject with Remsima if their physician determines that it is appropriate and with medical followup as necessary.
Maltese: Huwa importanti li tiċċekkja li t-tikketti tal-prodott biex tiżgura li tkun qed tingħata l formulazzjoni korretta skont ir-riċetta tat-tabib.
English: In an exploratory clinical study involving patients with moderate to severe COPD who were either current smokers or ex-smokers, 157 adult patients were treated with infliximab.
Maltese: Fi studju kliniku esploratorju li kien jinvolvi pazjenti b'COPD moderat sa sever li kienu jew ipejpu filpreżent jew kienu jpejpu fil-passat, 157 pazjent adult kienu kkurati b'infliximab.
English: In an exploratory clinical study involving patients with moderate to severe COPD who were either current smokers or ex-smokers, 157 adult patients were treated with infliximab at doses similar to those used in rheumatoid arthritis and Crohn's disease.
Maltese: Fi studju kliniku esploratorju li kien jinvolvi pazjenti b'COPD moderat sa sever li kienu jew ipejpu filpreżent jew kienu jpejpu fil-passat, 157 pazjent adult kienu kkurati b'infliximab b'dożi simili għal dawk użati f'artrite rewmatojde u l-marda ta' Crohn. Disgħa minn dawn il-pazjenti żviluppaw tumuri malinni, inkluża limfoma.
English: Remsima 100 mg powder for concentrate for solution for infusion
Maltese: Remsima 100 mg trab għal konċentrat għal soluzzjoni għall-infużjoni
English: Fabryczna 5A 00-446 Warszawa
Maltese: Fabryczna 5A 00-446
English: Agroseed Candilidis SA. Exit 1 of Attica Road, Thesi Xero Pigadi, Attikis 19600
Maltese: Exit 1 of Attica Road, Thesi Xero Pigadi, Attikis 19600
English: Palazzo Canova, Centro Direzionale Milano Due 20090 Segrate (Milano)
Maltese: Palazzo Canova, Centro Direzionale Milano Due 20090
English: Av. Río de Janeiro, 60-66 Planta 13, 08016 Barcelona (España)
Maltese: Río de Janeiro, 60-66 Planta 13, 08016 Barcelona (España)
English: Box: 27417 Cyprus
Maltese: Nicosia, P.O. Box: 27417 Cyprus
English: Date of last renewal: 18/12/2012.
Maltese: Data tal-aħħar tiġdid: 18/12/2012.
English: 10, Iasi 707410
Maltese: Tg.Frumos, km. 10, Iasi 707410
English: PB 3 08960.
Maltese: Constitución 1. PB 3 08960.
English: LT-08234 Vilnius, Lithuania
Maltese: LT-08234 Vilnius
English: Ecuphar Veterinaria S.L.U.
Maltese: Ecuphar Veterinaria S.
English: Cycon Chemicals Ltd 5 Promitheos Str 1065 Nicosia, P.O.
Maltese: Cycon Chemicals Ltd 5 Promitheos Str 1065
English: Maintenance dosage (ml)
Maltese: Doża tal-manteniment (ml)
English: Eurovet Animal Health B.V. Handelsweg 25, 5531 AE Bladel, The NETHERLANDS
Maltese: Eurovet Animal Health B.V. Handelsweg 25, 5531 AE Bladel, L-Olanda
English: Magyarország Orion Pharma Kft, 1139 Budapest, Pap Károly u. 4-6
Maltese: Kft, 1139 Budapest, Pap Károly u.
English: Blister
Maltese: BLISTERS
English: Lactose monohydrate Silicified microcrystalline cellulose Sodium acid citrate Crospovidone
Maltese: Lactose Monohydrate Silicified microcrystalline cellulose Sodium acid citrate Krospovidone
English: The major metabolites found in all species were the 5-hydroxyand 5-carboxy- metabolites and the oxalyl- metabolite.
Maltese: Il-metaboliti ewlenin li jinsabu f'kull speċi kienu lmetaboliti 5-hydroxy- u 5-carboxy u l-metabolit oxalyl.
English: Suomi/Finland Orion Pharma Eläinlääkkeet Pl 425, 20101 Turku
Maltese: Suomi/Finland Orion Pharma Eläinlääkkeet Pl 425, 20101
English: Tolnagro Állatgyógyászati Kft. 7100 Szekszárd, Rákóczi u. 142-146.
Maltese: Szekszárd, Rákóczi u. 142-146.
English: - Ethanol (96%) - Poloxamer 188 - Macrogol 400 - Glycine - Disodium edetate - Sodium hydroxide - Hydrochloric acid, concentrated - Meglumine - Water for injections
Maltese: - Poloxamer 188 - Macrogol 400 - Glycine - Sodium hydroxide - Hydrochloric acid - Meglumine - Ilma għall-injezzjonijiet
English: ORION CORPORATION P.O.Box 65 FI-02101, Espoo, Finland Reprezentat:
Maltese: FI-02101, Espoo, Finland Reprezentat:
English: Disodium edetate Sodium hydroxide Hydrochloric acid, concentrated Meglumine
Maltese: Disodium edetate Sodium hydroxide Hydrochloric acid Meglumine
English: Pack size: 100 sachets.
Maltese: Daqs tal-pakkett: 100 qratas.
English: Date of first authorisation: 10/01/2008 Date of last renewal: 18/12/2012
Maltese: Data tal-aħħar tiġdid: 18/12/2012
English: Magyarország Alpha-Vet 1194 Budapest, Hofherr A. u.
Maltese: Magyarország Alpha-Vet 1194
English: Paper foil sachets (paper/PE/alu/PE) containing 1.5 g granules per sachet in a cardboard box with 100 sachets.
Maltese: Qratas fojl Paper (karta/PE/alu/PE) li fihom 1.5 g granuli għal kull qartas f'kaxxa tal-kartun bi 100 qratas.
English: ORION CORPORATION P.O.Box 65 FI-02101, Espoo, Finland Predstavnik:
Maltese: FI-02101, Espoo, Finland Predstavnik:
English: Acute and chronic musculo-skeletal disorders.
Maltese: Mard muskolu-skeletriku akut u kroniku.
English: Date of first authorisation: 10/01/2008.
Maltese: Data tal-ewwel awtorizazzjoni: 10/01/2008.
English: Rheumocam 330 mg, granules for horses.
Maltese: Rheumocam 330 mg, granuli għaż-żwiemel.
English: Do not use after the expiry date (EXP) stated on the carton and vial.
Maltese: Tużax wara d-data tal-iskadenza (EXP) fuq il-kartuna u l-flixkun.
English: For example, a horse weighing 400 kg will receive 16 ml of Rheumocam, a horse weighing 500 kg will receive 20 ml of Rheumocam, and a horse weighing 600 kg will receive 24 ml of Rheumocam.
Maltese: Per eżempju, żiemel li jiżen 400 kg se jirċievu 16 ml ta' Rheumocam, żiemel li jiżen 500 kg se jirċievi 20 ml ta' Rheumocam, u żiemel li jiżen 600 kg se jirċievi 24 ml ta' Rheumocam.
English: Ποζειδώνος 77 174 55 Άλιμος, Αηηική
Maltese: Ποσειδώνος 77 174 55
English: Prodivet ZN, Nutrição e Comércio de Produtos Químicos, Farmacêuticos e Cosméticos, S.A. Av. Infante D. Henrique, nº 333-H, 3º Piso, Esc.41
Maltese: Prodivet ZN, Nutrição e Comércio de Produtos Químicos, Farmacêuticos e Cosméticos, S.A.
English: See section "Contraindications".
Maltese: Ara sezzjoni `Kontra-indikazzjonijiet´.
English: {Label for 100 ml}
Maltese: {Tikketta għal flixkun ta' 100 ml}
English: Excipient: Sodium benzoate 5 mg
Maltese: Sodium benzoate 5 mg
English: EU/2/07/078/005 EU/2/07/078/006 EU/2/07/078/007 EU/2/07/078/008
Maltese: EU/2/07/078/006 EU/2/07/078/007 EU/2/07/078/008
English: Bottle (HDPE)
Maltese: INDIKAZZJONI(JIET)
English: Maximum number of piercings is 14 for the 20 ml, 50 ml and 100 ml stoppers and 20 for the 250 ml stopper.
Maltese: Numru massimu ta' fetħiet huwa 14 għall-20 ml, 50 ml u 100 ml tappijiet u 20 għall-tapp ta' 250 ml.
English: PACKAGE LEAFLET: Rheumocam 330 mg granules for horses
Maltese: FIL-PAKKETT Rheumocam 330 mg, granuli għaż-żwiemel
English: Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway,
Maltese: Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co.
English: 100 ml: EU/2/07/078/002 200 ml: EU/2/07/078/003 15 ml: EU/2/07/078/004
Maltese: 100 ml: EU/2/07/078/002 200 ml: EU/2/07/078/003
English: The volume of distribution is 0.3 l/kg in dogs and 0.09 l/kg in cats.
Maltese: Ilvolum tad-distribuzzjoni hu ta' 0.3 l/kg fil-klieb u 0.09 l/kg fil-qtates.
English: Λεωθ.
Maltese: Λεωφ.
English: Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.
Maltese: Għas-serħan ta' wġigħ minn ħafif sa moderat u infjammazzjoni wara proċeduri kirurġiċi fil-qtates, eż. operazzjoni ortopedika u tat-tessut artab.
English: PVC/PVDC (250.
Maltese: Strixxi tal-PVC / PVDC (250. 60) li fihom fojl ta' 20 micron.
English: Number of chewable tablets mg/kg
Maltese: Numru ta' pilloli li jintmagħadu mg/kg
English: Rheumocam 15 mg/ml oral suspension for horses Meloxicam
Maltese: Rheumocam 15 mg/ml suspensjoni orali għaż-żwiemel Meloxicam
English: Each ml contains: 15 mg of meloxicam, 5 mg of sodium benzoate.
Maltese: Kull ml fih: 15 mg ta' meloxicam 5 mg ta' sodium benzoate
English: {Carton for 20 ml, 50 ml, 100 ml and 250 ml}
Maltese: {Kartuna għal fliexken ta' 20 ml, 50 ml, 100 ml jew 250 ml}
English: Meloxicam is eliminated with a half-life of 26 hours and 17.5 hours after subcutaneous injection in young cattle and lactating cows, respectively.
Maltese: Meloxicam jiġi eliminat b'half-life ta' 26 siegħa u 17.5 sigħat wara li jingħata b'injezzjoni taħt il-ġilda fi frat żgħar u f'baqar li jkunu li qed ireddgħu, rispettivament.
English: In vitro and in vivo studies demonstrated that meloxicam inhibits cyclooxygenase-2 (COX-2) to a greater extent than cyclooxygenase-1 (COX-1).
Maltese: Studji in vitro u in vivo urew li Meloxicam jinibixxi cyclooxygenase-2 (COX-2) b'mod iktar qawwi minn cyclooxygenase-1 (COX-1).
English: Pork Flavour
Maltese: Muskolu Fwied Kilwa
English: Meloxicam 20 mg/ml, Ethanol (96 percent) 159.8 mg/ml.
Maltese: Meloxicam 20 mg/ml Ethanol (96%) 159.8 mg/ml
English: Excipient: Ethanol (96 percent): 159.8 mg.
Maltese: Ethanol (96%) 159.8 mg
English: For Rheumocam 20 mg/ml solution for injection for cattle, pigs and horses and Rheumocam 5 mg/ml solution for injection for cats and dogs and Rheumocam 5 mg/ml solution for injection for cattle and pigs only:
Maltese: Għal soluzzjoni għall-injezzjoni Rheumocam 20 mg/ml għal baqar, majjali u żwiemel u soluzzjoni għall-injezzjoni Rheumocam 5 mg/ml għal klieb u qtates u Rheumocam 5 mg/ml soluzzjoni għall-injezzjoni għal baqar u majjali biss:
English: Post-operative pain and inflammation following surgical procedures: After initial treatment with Rheumocam 5 mg/ml solution for injection for cats, continue treatment 24 hours later with Rheumocam 0.5 mg/ml oral suspension for cats at a dosage of 0.05 mg meloxicam/kg body weight (0.1 ml /kg).
Maltese: Wara l-kura inizjali b'Rheumocam 5 mg/ml soluzzjoni għall-injezzjoni għal qtates, kompli l-kura 24 siegħa wara b'Rheumocam 0.5 mg/ml suspensjoni orali għal qtates f'dożaġġ ta' 0.05 mg ta' meloxicam/kg ta' piż tal-ġisem (0.1 ml /kg).
English: Dogs: single administration of 0.2 mg meloxicam /kg body weight (i.e. 0.4 ml/10 kg).
Maltese: Klieb: għoti ta' darba ta' 0.2 mg meloxicam/kg ta' piż tal-ġisem (i.e. 0.4 ml/10 kg).
English: EXP {month/year} Shelf-life of broached vial: 28 days.
Maltese: Kunjett miftuħ idum tajjeb: 28 jum.
English: IRELAND.
Maltese: L-IRLANDA.
English: Rheumocam 0.5 mg/ml oral suspension for cats meloxicam
Maltese: VETERINARJU Rheumocam 0.5 mg/ml suspensjoni orali għall-qtates meloxicam
English: PACKAGE LEAFLET: Rheumocam 15 mg/ml oral suspension for horses
Maltese: FIL-PAKKETT: Rheumocam 15 mg/ml suspensjoni orali għaż-żwiemel